Skip to main content

Early Detection Research Network (EDRN)

Visit the EDRN Website

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Rogers, Laura Q	University Of Alabama At Birmingham United States	Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors	5R01CA235598-06	Gabriela Riscuta, M.D., CNS
Rogers, Laura Q	University Of Alabama At Birmingham United States	Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors	5R01CA235598-06	Gabriela Riscuta, M.D., CNS
Rosenberg, Daniel William	University Of Connecticut Sch Of Med/Dnt United States	Microbiota, Metabolites, and Colon Neoplasia	5R01CA252045-05	Amit Kumar, Ph.D.
Rosenbluth, Jennifer M.	University Of California, San Francisco United States	In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer	4R01CA281361-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-03	Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-04	Guillermo Marquez, Ph.D.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S3	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	3UG1CA189861-11S1	Vanessa A. White, M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	3UG1CA189861-11S1	Vanessa A. White, M.P.H.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-05	Guillermo Marquez, Ph.D.

News and Events